Igal Shany is a General Partner at Viola Growth, where he invests in Series B–D, late-stage/growth, and private equity rounds across Digital Health, ClimateTech, Semiconductors, AI, Medical Devices, and Health Diagnostics. He invests in companies across Israel, the United States, and Germany. He serves on the boards of MDClone, Home365, Juganu, Scopio Labs, and KANDO Clear Upstream, and has invested in companies like MDClone, Home365, Juganu, Scopio Labs, and KANDO Clear Upstream. Before Viola Growth, he was Chief Executive Officer of Eitan Medical; prior to that, Managing Director at Aulder Capital (formerly BZ Investments LLC); and earlier Chief Financial Officer and GM Adquant at Skai. He attended Tel Aviv University and lives in Israel.
Igal Shany, General Partner @ Viola. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Igal Shany from Viola Growth. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Igal
Map your path to Igal instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Igal
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.